Clinical Evaluation of BW430C in Epilepsy<Phase III Study>
Clinical Evaluation of BW430C in Epilepsy
To evaluate safety information of BW430C when administered using the lower starting doses and slower dose escalations as recommended Global Data Sheet
Inclusion criteria:
Exclusion criteria: